Treatment of CIN 3
CIN 3 requires definitive treatment with either excisional procedures (LEEP, cold knife conization, or laser conization) or ablative procedures (cryotherapy or laser ablation), with excisional methods preferred when colposcopy is unsatisfactory. 1
Primary Treatment Options
When Colposcopy is Satisfactory
Both excision and ablation are acceptable treatment modalities for CIN 3 with satisfactory colposcopy. 2 The available treatment options include:
- LEEP (Loop Electrosurgical Excision Procedure) - Most commonly used excisional method 1
- Cold knife conization (CKC) - Preferred when microinvasion is suspected, as it provides better margin interpretation than LEEP 1
- Laser conization - Equivalent efficacy to other excisional methods 2
- Cryotherapy - Acceptable ablative option 1, 3
- Laser ablation - Acceptable ablative option 1
When Colposcopy is Unsatisfactory
A diagnostic excisional procedure (LEEP or CKC) is recommended for CIN 3 with unsatisfactory colposcopy. 2 This is critical because up to 7% of women with unsatisfactory colposcopy and CIN 2/3 have occult invasive cervical carcinoma. 2
Recurrent CIN 3
Excisional modalities are strongly preferred for recurrent CIN 3 after previous ablative therapy. 2 Recurrent disease frequently occurs in the endocervical canal where it is not colposcopically detectable, making ablation unsuitable. 2
Important Caveats
What is NOT Acceptable
- Observation with sequential cytology and colposcopy is unacceptable for CIN 3, except in special circumstances (pregnancy, adolescents, immunosuppressed women). 2
- Hysterectomy is unacceptable as primary therapy for CIN 3. 2 However, hysterectomy may be considered if other indications exist (symptomatic fibroids, persistent abnormal bleeding) AND after initial excisional procedure confirms the diagnosis. 1
Pre-Treatment Requirements
Endocervical sampling is recommended before ablation of CIN lesions to exclude occult invasive disease. 2 Studies show that women with negative endocervical curettage had no subsequent invasive disease, while all 17 women with invasive disease had positive endocervical sampling. 2
Post-Treatment Follow-Up
Surveillance Strategy
Follow-up consists of either:
For excisional procedures with negative margins: cytology at 6 months or HPV testing at 12 months is recommended. 1
For excisional procedures with positive margins, three options exist:
- Cervical cytology at 6 months (with ECC considered as category 2B recommendation) 1
- Re-excision, especially if invasion is suspected 1
- Consider hysterectomy 1
Return to Routine Screening
After 2 consecutive negative cytology results or negative HPV testing, routine screening may resume, but should continue for at least 20 years. 4 If HPV DNA testing is positive or repeat cytology shows ASC-US or greater, colposcopy is recommended. 1, 2
For Ablative Procedures
Surgical margins cannot be assessed after cryotherapy or laser ablation, so follow-up with cervical cytology at 6 months or HPV DNA testing at 12 months is essential. 1
Special Considerations
Microinvasion Suspected
Cold knife conization should be performed when microinvasive biopsy findings are present, as LEEP is associated with cautery artifact that may compromise pathologic evaluation. 1 Any confirmed invasive cancer requires treatment according to cervical cancer guidelines. 1
Treatment Efficacy
The WHO guidelines note that treatment of CIN 2-3 with cryotherapy, LEEP, or cold knife conization is very effective, simple, and safe. 3, 5 The cure rate after ablative treatment may be slightly lower than excisional treatment, but the simplicity and low complication rate make ablation acceptable for eligible lesions. 5
Emerging Therapies
Medical therapies (topical imiquimod, 5-fluorouracil, cidofovir) are NOT currently recommended for CIN 3 treatment, as surgery remains the standard of care. 6, 7 One recent study showed imiquimod had only 60% success rate compared to 95% for LLETZ. 8